Voyageur Pharmaceuticals (CVE:VM) Stock Price Down 27.5% – Time to Sell?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) dropped 27.5% during mid-day trading on Wednesday . The company traded as low as C$0.18 and last traded at C$0.19. Approximately 1,664,770 shares traded hands during mid-day trading, an increase of 697% from the average daily volume of 208,961 shares. The stock had previously closed at C$0.26.

Voyageur Pharmaceuticals Stock Performance

The company has a debt-to-equity ratio of 4.23, a quick ratio of 0.84 and a current ratio of 0.10. The company has a market capitalization of C$28.79 million, a P/E ratio of -17.77 and a beta of 0.32. The business’s fifty day simple moving average is C$0.22 and its 200-day simple moving average is C$0.18.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Stories

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.